CN Patent
CN101248038A — 替加环素的结晶固体形式及其制备方法
Assigned to Wyeth LLC · Expires 2008-08-20 · 18y expired
What this patent protects
本文描述了替加环素的结晶固体形式、即I型、II型、III型、IV型和V型、包含这些结晶固体形式的组合物以及制备这些结晶固体形式的方法。
USPTO Abstract
本文描述了替加环素的结晶固体形式、即I型、II型、III型、IV型和V型、包含这些结晶固体形式的组合物以及制备这些结晶固体形式的方法。
Drugs covered by this patent
- Tygacil (TIGECYCLINE) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.